ClinicalTrials.gg
Drug

Micafungin clinical trials

Also written Mycamine and FK463.

studies test it
49
open now
1
in phase 3
13
first study started
1998

How each study uses Micafungin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Micafungin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
16 Mar 2005 · MYCAMINE · NDA 021506 (FDA, Drugs@FDA)
European Union
25 Apr 2008 · Mycamine · EMEA/H/C/000734 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Micafungin
39
Micafungin sodium
3
micafungin (Mycamine)
2

Brand

Mycamine
21

Development codes

FK463
20

Studies by the year they started

49 studies that test it; most in 2007 (6)

Studies that test Micafungin, by start year
YearStudies
19981
19993
20021
20033
20043
20062
20076
20082
20092
20103
20113
20123
20134
20144
20152
20171
20181
20211
20223
20241

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
12
Phase 3
13
Phase 4
17

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 24 · Other 25

Astellas Pharma Inc (18) · Astellas Pharma China, Inc. (3) · Astellas Pharma Global Development, Inc. (2) · Seoul National University Hospital (2) · Children's Hospital Medical Center, Cincinnati (2) · National Cancer Institute (NCI) (2) · Asan Medical Center (2) · Institut National de la Santé Et de la Recherche Médicale, France (1)

Often tested with

Tested in the same studies.

Fluconazole (3) · Voriconazole (2) · Caspofungin (1) · Posaconazole (1) · Liposomal amphotericin B (1) · Amphotericin B (1) · Meropenem (1)

Studies

Open first, then newest update. How each study uses Micafungin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 49

See all 49 studies that test Micafungin →

Given beside what is tested · 2 — Micafungin is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Micafungin

Codes

What other systems call Micafungin · ClinicalTrials.gg INT006747

  • MeSH (NLM) D000077551MicafunginConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) R10H71BSWGMICAFUNGINConfirmed FDA, NLM, Wikidata
  • RxNorm 325887Confirmed FDA, Wikidata
  • Wikidata Q6827850micafunginConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1850MicafunginOne source FDA
  • DrugBank DB01141One source Wikidata

Also registered as micafungin sodium (UNII IS1UP79R56 · RxNorm 487070).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.